Guggenheim Second Quarter 2025 High Yield and Bank Loan Outlook: Credit Crossroads: Finding Value in an Era of Uncertainty
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- Guggenheim Investments, the global asset management and investment advisory business of Guggenheim Partners, today released its second quarter High Yield and Bank Loan Outlook. "Credit Crossroads: Finding Value in an Era of Uncertainty," examines the ...
From Onboarding to Settlement in Minutes: TransFi Launches BizPay to Redefine Global Business Payments
TransFi launches BizPay, a unified global payment platform enabling instant, compliant cross-border transactions with AI-powered routing and 250+ local methods across 100+ countries
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TMCI - Treace Medical Concepts ( NASDAQ:TMCI )
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Treace Medical Concepts, Inc. TMCI between May 8, 2023 and May 7, 2024, both dates inclusive ( the "Class Period" ) , of the important June 10, 2025 lead ...
First Capital, Inc. Announces Quarterly Dividend - First Cap ( NASDAQ:FCAP )
CORYDON, Ind., May 22, 2025 ( GLOBE NEWSWIRE ) -- The Board of Directors of First Capital, Inc. FCAP has declared a quarterly cash dividend of $0.29 ( twenty-nine cents ) per share of common stock, according to Michael C. Frederick, President and Chief Executive Officer.
Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq
Cincinnati, OH, May 22, 2025 ( GLOBE NEWSWIRE ) -- Onconetix, Inc. ( Nasdaq: ONCO ) ( the "Company" ) announced that it received a Staff delisting letter from The Nasdaq Capital Market ( "Nasdaq" ) on May 20, 2025 indicating that the Company's failure to file its Quarterly Report on Form 10-Q ...
Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors
- Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics ...
UroGen Pharma Ltd. ( URGN ) Shares Crash Again Amid FDA's ODAC Vote Against UGN-102, Company Facing Investor Scrutiny - Hagens Berman - UroGen Pharma ( NASDAQ:URGN )
SAN FRANCISCO, May 22, 2025 ( GLOBE NEWSWIRE ) -- On May 21, 2025, investors in UroGen Pharma Ltd. ( NASDAQ:URGN ) saw the price of their shares crash 44% after the company announced that the FDA's Oncologic Drugs Advisory Committee ( "ODAC" ) voted against the risk/benefit profile of UroGen's ...
Ross Stores Stock Plunges After Pulling Fiscal 2026 Revenue, Earnings Guidance: Details - Ross Stores ( NASDAQ:ROST )
Ross Stores pulls its fiscal 2026 EPS and revenue guidance. The company reports quarterly earnings of $1.47 per share, which beat the Street estimate of $1.44. Get 5 'Hidden Gem' stock picks and daily rankings-now 60% off for Memorial Day. Ross Stores, Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
NEW YORK, May 22, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds persons or entities that ( 1 ) sold or otherwise disposed of the publicly-traded common stock of Cerevel Therapeutics Holdings, Inc.
